Correlation between 25-hydroxy-vitamin D and Parkinson's disease
Background: Previous cross-sectional studies have shown that Parkinson’s disease (PD) patients have lower serum 25-hydroxyvitamin D (25(OH)D) concentrations than controls. Other studies have not yet tested whether research findings from other regions are generalizable to Chinese populations. In this...
Main Authors: | Ming Xia, Qingjiu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | IBRO Neuroscience Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123000167 |
Similar Items
-
Association between Serum Alpha-Synuclein Levels and Parkinson's Disease Stage
by: Yuliarni Syafrita, et al.
Published: (2022-08-01) -
Functional gait assessment in early and advanced Parkinson’s disease
by: Hany Mohamed Eldeeb, et al.
Published: (2021-10-01) -
The variation in free 25-hydroxy vitamin D and vitamin D-binding protein with season and vitamin D status
by: Göran Oleröd, et al.
Published: (2017-01-01) -
Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study
by: Hiroshi Kataoka, et al.
Published: (2021-05-01) -
Circulatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
by: Hiromu Ogura, et al.
Published: (2021-12-01)